← Back to Search

Procedure

ELIOS Procedure for Glaucoma

N/A
Recruiting
Research Sponsored by Elios Vision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 45 years old
Diagnosis of mild to moderate POAG
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tested a procedure to reduce eye pressure in those with mild-moderate glaucoma, showing it was safe and effective.

Who is the study for?
This trial is for adults at least 45 years old with mild to moderate primary open-angle glaucoma (POAG). Participants should have a Shaffer angle grade of III or IV, medicated intraocular pressure (IOP) of 24 mmHg or less, and a cup-to-disc (CD) ratio of up to 0.8.
What is being tested?
The ELIOS System procedure is being tested for its ability to safely reduce eye pressure in patients with POAG. The study will assess how well the procedure works and monitor any potential complications.
What are the potential side effects?
While specific side effects are not listed, typical risks may include discomfort at the site of the procedure, temporary vision changes, increased eye pressure, inflammation, or infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 45 years old.
Select...
I have been diagnosed with mild to moderate open-angle glaucoma.
Select...
My eye pressure is 24 mmHg or lower with medication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean Change in DIOP from baseline on the same or fewer medications
Proportion of subjects who achieve a decrease in mean diurnal IOP (DIOP) from baseline of at least 20% on the same or fewer medications

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ELIOS ProcedureExperimental Treatment1 Intervention
ELIOS Procedure

Find a Location

Who is running the clinical trial?

Elios Vision, Inc.Lead Sponsor
2 Previous Clinical Trials
512 Total Patients Enrolled
2 Trials studying Glaucoma
512 Patients Enrolled for Glaucoma
Iqbal (Ike) Ahmed, MDStudy DirectorPrism Eye Institute
1 Previous Clinical Trials
318 Total Patients Enrolled
1 Trials studying Glaucoma
318 Patients Enrolled for Glaucoma
~28 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top